Life Sciences on way back after poor year
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.LIFE Sciences International, Sir Christopher Bland's other company, has made a strong start to the year after a difficult 1993, writes Paul Durman.
The laboratory equipment maker headed by the LWT chairman would have suffered a profits setback last year but for a strong contribution from Labsystems, the Finnish company bought last June. Labsystems made pounds 5.1m out of total pre-tax profits of pounds 23m, a 12 per cent increase on the previous year.
Sir Christopher said the US, which accounts for more than half of Life Sciences' pounds 154m of sales, was very flat last year ahead of Hillary Clinton's healthcare reforms. But it had a strong January and February. The health reforms were 'going to mean less than (was) feared'.
The company has made a provision of about pounds 800,000 after losing a patent infringement lawsuit dating from 1985. It has written off a similar amount against Shandon's demonstration equipment.
Sir Christopher hoped Labsystems would enable the group to establish itself in the important Japanese market. Life Sciences has parted company with Donald Cameron, whom it recruited 18 months ago to try to build up Japanese sales.
Earnings per share rose 3 per cent to 9.4p. A final dividend of 2.5p lifts the total 10 per cent to 3.9p.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments